A citation-based method for searching scientific literature

Emanuela Minna, Paola Romeo, Matteo Dugo, Loris De Cecco, Antonella Aiello, Federico Pistore, Andrea Carenzo, Angela Greco, Maria Grazia Borrello. Cancers (Basel) 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Label-free intraoperative parathyroid localization with near-infrared autofluorescence imaging.
Melanie A McWade, Constantine Paras, Lisa M White, John E Phay, Carmen C Solórzano, James T Broome, Anita Mahadevan-Jansen. J Clin Endocrinol Metab 2014
87
50

Comparison of 68Ga PET/CT to Other Imaging Studies in Medullary Thyroid Cancer: Superiority in Detecting Bone Metastases.
Luciana Audi Castroneves, George Coura Filho, Ricardo Miguel Costa de Freitas, Raphael Salles, Raquel Ajub Moyses, Rossana Veronica Mendoza Lopez, Maria Adelaide Albergaria Pereira, Marcos Roberto Tavares, Alexander Augusto de Lima Jorge, Carlos Alberto Buchpiguel,[...]. J Clin Endocrinol Metab 2018
21
50

FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With RET Gene Mutations or Fusions.
Janice Kim, Diana Bradford, Erin Larkins, Lee H Pai-Scherf, Somak Chatterjee, Pallavi S Mishra-Kalyani, Emily Wearne, Whitney S Helms, Amal Ayyoub, Youwei Bi,[...]. Clin Cancer Res 2021
24
50

RAS proto-oncogene in medullary thyroid carcinoma.
Margarida M Moura, Branca M Cavaco, Valeriano Leite. Endocr Relat Cancer 2015
58
50

Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma.
Gilbert J Cote, Caitlin Evers, Mimi I Hu, Elizabeth G Grubbs, Michelle D Williams, Tao Hai, Dzifa Y Duose, Michal R Houston, Jacquelin H Bui, Meenakshi Mehrotra,[...]. J Clin Endocrinol Metab 2017
40
50

Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
G Hajje, I Borget, S Leboulleux, C Chougnet, A Al Ghuzlan, H Mirghani, C Caramella, D Hartl, M Schlumberger, E Baudin. Eur J Endocrinol 2012
11
50

Cardiac Metastasis from Medullary Thyroid Cancers with Long-Term Survival under Vandetanib.
Camille Buffet, Sophie Leboulleux, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Laure Cabanes, Anthony Dohan, Pascal Leprince, Martin Schlumberger, Olivier Huillard, Lionel Groussin. Eur Thyroid J 2021
1
100

Evaluation of Parathyroid Glands with Indocyanine Green Fluorescence Angiography After Thyroidectomy.
Anatoliy V Rudin, Travis J McKenzie, Geoffrey B Thompson, David R Farley, Melanie L Lyden. World J Surg 2019
38
50

Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
A Miyauchi, F Matsuzuka, K Hirai, T Yokozawa, K Kobayashi, S Kuma, K Kuma, H Futami, K Yamaguchi. World J Surg 2000
32
50

Thyroid cancer surgery - in what direction are we going? A mini-review.
Krzysztof Kaliszewski, Beata Wojtczak, Krzysztof Sutkowski, Jerzy Rudnicki. J Int Med Res 2020
4
50

Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study.
Christof Rottenburger, Guillaume P Nicolas, Lisa McDougall, Felix Kaul, Michal Cachovan, A Hans Vija, Roger Schibli, Susanne Geistlich, Anne Schumann, Tilman Rau,[...]. J Nucl Med 2020
30
50

Management of Medullary Thyroid Cancer.
David Viola, Rossella Elisei. Endocrinol Metab Clin North Am 2019
31
50

Translating the immune microenvironment of thyroid cancer into clinical practice.
Lucas Leite Cunha, Laura Sterian Ward. Endocr Relat Cancer 2022
3
50

Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma.
Friedhelm Raue, Thomas Bruckner, Karin Frank-Raue. J Clin Endocrinol Metab 2021
6
50

Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.
Israel Pena, Gary L Clayman, Elizabeth G Grubbs, Jeffrey M Bergeron, Steven G Waguespack, Maria E Cabanillas, Ramona Dadu, Mimi I Hu, Bryan M Fellman, Yisheng Li,[...]. Head Neck 2018
15
50

Medullary thyroid cancer: molecular factors, management and treatment.
Efstathios Pavlidis, Konstantinos Sapalidis, Fotios Chatzinikolaou, Isaak Kesisoglou. Rom J Morphol Embryol 2020
2
50

Novel techniques for intraoperative parathyroid gland identification: a comprehensive review.
Amanda Wong, Jovi C Y Wong, Prashant U Pandey, Sam M Wiseman. Expert Rev Endocrinol Metab 2020
11
50

Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013.
Evan Olson, Grant Wintheiser, Katrina M Wolfe, Jonathan Droessler, Peter T Silberstein. Cureus 2019
54
50

Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer.
Yongkun Sun, Feng Du, Ming Gao, Qinghai Ji, Zhendong Li, Yuan Zhang, Zhuming Guo, Jun Wang, Xiangjin Chen, Jinwan Wang,[...]. Thyroid 2018
66
50

Suboptimal accuracy of ultrasound and ultrasound-based risk stratification systems in detecting medullary thyroid carcinoma should not be overlooked. Findings from a systematic review with meta-analysis.
Giulia Ferrarazzo, Chiara Camponovo, Maurilio Deandrea, Arnoldo Piccardo, Lorenzo Scappaticcio, Pierpaolo Trimboli. Clin Endocrinol (Oxf) 2022
1
100

EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.
Luca Giovanella, Giorgio Treglia, Ioannis Iakovou, Jasna Mihailovic, Frederik A Verburg, Markus Luster. Eur J Nucl Med Mol Imaging 2020
39
50

Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE® databases.
D-J van Beek, M Almquist, A O Bergenfelz, T J Musholt, E Nordenström. Br J Surg 2021
4
50

Novel targeted therapies and immunotherapy for advanced thyroid cancers.
George E Naoum, Michael Morkos, Brian Kim, Waleed Arafat. Mol Cancer 2018
106
50

Current Guidelines for Management of Medullary Thyroid Carcinoma.
Mijin Kim, Bo Hyun Kim. Endocrinol Metab (Seoul) 2021
9
50

Prophylactic Lateral Neck Dissection for Medullary Thyroid Carcinoma is not Associated with Improved Survival.
Philip M Spanheimer, Ian Ganly, Joanne F Chou, Marinela Capanu, Aradhya Nigam, Ronald A Ghossein, R Michael Tuttle, Richard J Wong, Ashok R Shaha, Murray F Brennan,[...]. Ann Surg Oncol 2021
10
50

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.
V Subbiah, T Shen, S S Terzyan, X Liu, X Hu, K P Patel, M Hu, M Cabanillas, A Behrang, F Meric-Bernstam,[...]. Ann Oncol 2021
70
50

Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.
Anne Laure Giraudet, Abir Al Ghulzan, Anne Aupérin, Sophie Leboulleux, Ahmed Chehboun, Frédéric Troalen, Clarisse Dromain, Jean Lumbroso, Eric Baudin, Martin Schlumberger. Eur J Endocrinol 2008
150
50

The Current Histologic Classification of Thyroid Cancer.
Sylvia L Asa. Endocrinol Metab Clin North Am 2019
42
50

Computed Tomography and MR Imaging of Thyroid Disease.
Katie Suzanne Traylor. Radiol Clin North Am 2020
5
50

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
988
50

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Sena Turkdogan, Véronique-Isabelle Forest, Michael P Hier, Michael Tamilia, Anca Florea, Richard J Payne. J Otolaryngol Head Neck Surg 2018
17
50

MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives.
Francesca Galuppini, Simona Censi, Margherita Moro, Stefano Carraro, Marta Sbaraglia, Maurizio Iacobone, Matteo Fassan, Caterina Mian, Gianmaria Pennelli. Cells 2021
3
50

Efficacy and safety of concomitant 177Lu-DOTATATE and low-dose capecitabine in advanced medullary thyroid carcinoma: a single-centre experience.
Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Roshan Verma, Naresh Panda. Nucl Med Commun 2020
9
50

Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study.
Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato,[...]. J Nucl Med 2021
6
50


External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
Michael Jin, Uchechukwu C Megwalu, Julia E Noel. Otolaryngol Head Neck Surg 2021
5
50

Medullary thyroid cancer: What is the optimal management of the lateral neck in a node negative patient at index operation?
Thomas Szabo Yamashita, Richard T Rogers, Trenton R Foster, Melanie L Lyden, John C Morris, Geoffrey B Thompson, Travis McKenzie, Benzon M Dy. Surgery 2022
1
100

Drugging the Undruggable: Advances on RAS Targeting in Cancer.
Miriam Molina-Arcas, Amit Samani, Julian Downward. Genes (Basel) 2021
19
50

Novel Inhibitor-Based Therapies for Thyroid Cancer-An Update.
Maciej Ratajczak, Damian Gaweł, Marlena Godlewska. Int J Mol Sci 2021
10
50

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux,[...]. N Engl J Med 2020
216
50

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
685
50

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations.
Rossella Elisei, Alessia Tacito, Teresa Ramone, Raffaele Ciampi, Valeria Bottici, Virginia Cappagli, David Viola, Antonio Matrone, Loredana Lorusso, Laura Valerio,[...]. Genes (Basel) 2019
29
50

Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).
Krzysztof Kaliszewski, Maksymilian Ludwig, Maria Greniuk, Agnieszka Mikuła, Karol Zagórski, Jerzy Rudnicki. Cancers (Basel) 2022
3
50

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Cristina Romei, Raffaele Ciampi, Rossella Elisei. Nat Rev Endocrinol 2016
175
50

The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway.
Else Marie Opsahl, Lars Andreas Akslen, Ellen Schlichting, Turid Aas, Katrin Brauckhoff, Anne Irene Hagen, Alf Frimann Rosenlund, Eva Sigstad, Krystyna K Grøholt, Lars H Jørgensen,[...]. Eur Thyroid J 2019
16
50

A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study.
Paola A Erba, Helmut Maecke, Renata Mikolajczak, Clemens Decristoforo, Katja Zaletel, Theodosia Maina-Nock, Petra Kolenc Peitl, Piotr Garnuszek, Alida Froberg, Georg Goebel,[...]. Pol Arch Intern Med 2018
13
50

Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model.
Paul Tappenden, Christopher Carroll, Jean Hamilton, Eva Kaltenthaler, Ruth Wong, Jonathan Wadsley, Laura Moss, Sabapathy Balasubramanian. Health Technol Assess 2019
19
50

Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors.
Loredana Lorusso, Cristina Romei, Paolo Piaggi, Chiara Fustini, Eleonora Molinaro, Laura Agate, Valeria Bottici, David Viola, Giovanni Pellegrini, Rossella Elisei. Thyroid 2021
6
50

Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Martin B Niederle, Christian Scheuba, Philipp Riss, Andreas Selberherr, Oskar Koperek, Bruno Niederle. Thyroid 2020
23
50

Thyroid volume and serum calcitonin changes during pregnancy.
G Vannucchi, D Covelli, B Vigo, M Perrino, L Mondina, L Fugazzola. J Endocrinol Invest 2017
10
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.